Table 2.

Characteristics of groups discordant for Homeostatic Model Assessment for Insulin Resistance and Adipose Insulin Resistance index palmitate concentrations

	LHMA group		HHMA group		MHLA group		MHHA group
	n	Mean ± SD	n	Mean ± SD	n	Mean ± SD	n	Mean ± SD
Age, y	30	41 ± 20	25	37 ± 19	30	37 ± 16	26	46 ± 21
Sex, female/male	30	16/14	25	12/13	30	16/14	26	13/13
BMI, kg/m2	30	23.4 ± 3.1a,c	25	27.2 ± 3.8	30	24.7 ± 4.7e	26	27.1 ± 4.9
TGs, mg/dL	27	107 ± 48	25	112 ± 63	27	87 ± 26b	24	118 ± 48
TCHO, mg/dL	27	169 ± 31	25	165 ± 28	26	168 ± 35	24	172 ± 40
HDL-C, mg/dL	26	51 ± 14	25	48 ± 15	27	56 ± 21	26	47 ± 18
FFM, kg	30	52.2 ± 11.4	25	53.7 ± 12.8	30	53.4 ± 13.8	26	51.8 ± 8.9
FM, kg	30	17.8 ± 7.4b,d	25	26.2 ± 10.2	30	19.5 ± 11.2b,e	26	26.1 ± 12.8
% FM	30	25.4 ± 9.7b,e	25	32.4 ± 10.8	30	26.2 ± 10.2e	26	32.4 ± 12.6
CT visceral FM, cm2	28	69 ± 65b	25	90 ± 60	30	68 ± 78a,e	26	129 ± 93
CT subcutaneous FM, cm2	28	108 ± 62b,c	25	191 ± 95	30	116 ± 106b,d	26	189 ± 119
UB subcutaneous FM, kg	25	9.3 ± 3.8e	24	13.2 ± 5.3	28	10.1 ± 6.2e	22	11.9 ± 5.8
Leg fat, kg	27	6.8 ± 2.9e	24	10.0 ± 4.7	28	7.4 ± 4.3e	23	9.1 ± 4.9
Leg fat/Whole-body fat	28	0.36 ± 0.09	24	0.38 ± 0.06	28	0.38 ± 0.05	23	0.36 ± 0.06

Data presented as mean value and SD.

Abbreviations: % FM, percentage of fat mass; ADIPO_palmitate-IR, Adipose Insulin Resistance index palmitate concentration; BMI, body mass index; CT, computed tomography; FFM, fat-free mass; FM, fat mass; HDL-C, high-density lipoprotein cholesterol; HHMA, high HOMA-IR and medium ADIPO_palmitate-IR; HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; LHMA, low HOMA-IR and medium ADIPO_palmitate-IR; MHHA, medium HOMA-IR high ADIPO_palmitate-IR; MHLA, medium HOMA-IR and low ADIPO_palmitate-IR; TCHO, total cholesterol; TG, plasma triglycerides; UB subcutaneous FM, upper body subcutaneous fat mass.

^a P less than .01 vs MHHA.

^b P less than .05 vs MHHA.

^c P less than .001 vs HHMA.

^d P less than .01 vs HHMA.

^e P less than .05 vs HHMA.